Pharma News
13 mins ago
Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Celltrion and currently in Phase I for Osteoporosis.…
Pharma News
45 mins ago
Denosumab biosimilar by Sandoz Group for Giant Cell Tumor Of Bone: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks…
Pharma News
1 hour ago
Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks…
Pharma News
3 hours ago
Odevixibat by Ipsen for Biliary Atresia: Likelihood of Approval
Odevixibat is under clinical development by Ipsen and currently in Phase III for Biliary Atresia.…
News
3 hours ago
Do Women Need More Sleep Than Men?
Highlights:
Women generally need more sleep than men due to hormonal fluctuations, multitasking, and…
News
5 hours ago
Cervical Cancer Prevention Beyond Age 26
Although the recommended age for receiving the HPV vaccine is between 9 and 14, women…
Pharma News
5 hours ago
Orchard’s gene therapy for MLD finally gets US approval
The FDA has cleared its first gene therapy for children with metachromatic leukodystrophy (MLD), a…
News
5 hours ago
India Exceeds WHO Guidelines: 1:900 Doctor-Population Ratio
Rajya Sabha MP Bhubaneswar Kalita, also Chairperson of the Parliamentary Standing Committee on Health and…
Pharma News
6 hours ago
Adalimumab biosimilar by Biocon for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
Adalimumab biosimilar is under clinical development by Biocon and currently in Phase III for Plaque…
Pharma News
7 hours ago
Mould study highlights safer far-UVC light cleaning alternative
Research suggests that to prevent common mould growth, low-dose far-UVC light could be applied as…